13F Filings History of Enavate Sciences GP, LLC

Latest 13F report
Q3 2025 - 14 Nov 2025
Value $
$327,524,118
Signature - Title
James P. Boylan - Chief Executive Officer
Location
New York, NY
Summary
This page shows a list of all the recent 13F filings made by Enavate Sciences GP, LLC. Form 13F is required to be filed within 45 days of the end of a calendar quarter. Enavate Sciences GP, LLC reported 7 stock holdings with total value $327,524,118 as of Q3 2025. Top holdings included ZBIO, SION, IMNM, UPB, and BBOT.

Notify me when Enavate Sciences GP, LLC files a new 13F portfolio report.

⭐ Subscribe ⭐
Holdings Value
Quarter Holdings Value $ Bought Sold Net Top Holdings Form Type Filing Time
Q3 2025 7 $327,524,118 +$30,420,035 $0 +$30,420,035 ZBIO, SION, IMNM, UPB, BBOT 13F-HR 14 Nov 2025, 16:16
Q2 2025 6 $176,535,354 $0 $0 $0 IMNM, SION, ZBIO, UPB, CMPX 13F-HR 14 Aug 2025, 16:18
Q1 2025 6 $132,721,569 +$34,604,061 $0 +$34,604,061 IMNM, ZBIO, SION, CAMP, UPB 13F-HR 15 May 2025, 16:17
Q4 2024 5 $139,236,883 $0 $0 $0 UPB, IMNM, ZBIO, CAMP, CMPX 13F-HR 14 Feb 2025, 16:15